ALLERGAN LIMITED
Get an alert when ALLERGAN LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-04 (in 1mo)
Last made up 2025-05-21
Watchouts
Cash
£13K
0% vs 2023
Net assets
£228M
+4% vs 2023
Employees
0
Average over period
Profit before tax
£11M
+11% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
We draw attention to Note 2 of the financial statements which explains that the company has ceased to trade during 2022 and therefore the directors do not consider it appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly, the financial statements have been prepared on a basis other than going concern as described in Note 2. Our opinion is not modified in respect of this matter.
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | — | -£152,000 | |
| Profit before tax | £10,280,000 | £11,410,000 | |
| Net profit | £7,862,000 | £8,795,000 | |
| Cash | £13,000 | £13,000 | |
| Total assets less current liabilities | — | — | |
| Net assets | £219,088,000 | £227,883,000 | |
| Equity | £219,088,000 | £227,883,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Current ratio | 79.25x | 72.37x | |
| Interest cover | — | -10.13x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to Note 2 of the financial statements which explains that the company has ceased to trade during 2022 and therefore the directors do not consider it appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly, the financial statements have been prepared on a basis other than going concern as described in Note 2. Our opinion is not modified in respect of this matter.”
Significant events
- “On 1 April 2022 AbbVie Ltd and Allergan Limited entered into a Business Transfer Agreement whereby Allergan Limited transferred its operations, assets and liabilities (excluding corporation tax balances) to AbbVie Ltd as part of a restructuring plan. Following the transfer, the company maintains a limited operational role. The company is advancing towards completing the legal processes required for its planned future liquidation as part of the ongoing restructuring process.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 52 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HUDSON, Nick, Mr. | Director | 2019-02-07 | Nov 1975 | British |
| JOHNSON, Paul, Mr. | Director | 2018-08-20 | Dec 1972 | British |
| SIBLEY, Aaron Mark | Director | 2019-02-07 | Aug 1977 | British |
Show 52 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALDERSON, Jeffrey | Secretary | — | 1994-04-05 |
| DENG, Ying, Ms. | Secretary | 2020-10-02 | 2021-07-05 |
| HARAN, Patricia Maria | Secretary | 2018-02-19 | 2021-07-05 |
| HINDMAN, James | Secretary | 1994-04-05 | 1996-02-01 |
| MORTLOCK, Peter | Secretary | 1996-02-01 | 1996-09-13 |
| NELLIGAN, Tom | Secretary | 2015-06-26 | 2017-10-13 |
| SAUERMAN, Anthony | Secretary | 2002-02-22 | 2015-06-26 |
| STEINHOLTZ, Ruth Nancy | Secretary | 1998-03-01 | 2002-02-22 |
| STIDDARD, Andrew John | Secretary | 1996-09-13 | 1998-03-01 |
| TOMKINS, Judith | Secretary | 2018-02-19 | 2020-10-02 |
| ALVAREZ, Fernando, Mr. | Director | 2020-09-29 | 2021-11-19 |
| ASHER, Kevin | Director | 2018-08-20 | 2019-02-07 |
| BARBORKA, Drake | Director | 2001-05-18 | 2005-01-31 |
| BEEKMAN, Maarten Jan Har | Director | 1997-04-04 | 2001-11-01 |
| BRANAGAN, John Paul, Dr | Director | 2001-11-01 | 2005-11-01 |
| BRUNS, David Bernard | Director | — | 1992-02-29 |
| CARRUTHERS, David, Dr. | Director | 2019-02-07 | 2023-12-08 |
| CHAPPELL, Carole | Director | 2005-06-01 | 2014-11-27 |
| CHARBONEAU, Gary | Director | 2014-11-27 | 2015-06-29 |
| COOKE, Damon James | Director | 2017-02-10 | 2017-08-31 |
| DONOHOE, Michael Joseph | Director | 1993-09-14 | 1998-04-16 |
| DRAKE, Dawn | Director | 2017-08-14 | 2018-05-02 |
| ENDICOTT, David John | Director | 2005-01-01 | 2010-09-01 |
| ENGEL, Thim | Director | 2007-03-07 | 2008-08-04 |
| FELLOWS, David Andrew | Director | 2002-06-01 | 2004-11-28 |
| FULFORD SMITH, Antony | Director | 2008-09-02 | 2012-12-01 |
| GHATTAS, Nancy, Ms. | Director | 2019-02-07 | 2020-05-28 |
| GILLEN, Martin | Director | 2013-04-02 | 2014-05-31 |
| GRIPPON, Laurent | Director | 2019-02-07 | 2019-11-30 |
| HAYWARD, Esther | Director | 2014-06-01 | 2015-03-30 |
| HO, Selwyn Justin | Director | 2011-01-21 | 2012-07-27 |
| IGLESIAS-FERNANDEZ, Luis | Director | 2016-01-27 | 2017-03-16 |
| INGRAM, Douglas | Director | 2001-07-22 | 2005-11-01 |
| JONES, Gordon Eric | Director | — | 1996-06-30 |
| JONES, Kenneth Wade | Director | 1996-07-01 | 2001-05-24 |
| KERR, Samantha Marjorie | Director | 2012-12-01 | 2018-08-20 |
| LIN, Sue Jean | Director | 2005-06-01 | 2007-03-02 |
| MASSEY, Nicola | Director | 2017-02-10 | 2018-06-11 |
| MAZZO, James Vito | Director | 1998-04-16 | 2002-05-31 |
| NEWTON, Simon Peter | Director | 2012-12-01 | 2014-10-11 |
| PURNELL, Jacqueline Ann | Director | 2017-02-10 | 2017-09-05 |
| RAWSON, Andrew John | Director | 2012-12-01 | 2015-12-31 |
| REICHARDT, Diethardt | Director | — | 1993-08-16 |
| SEHGAL, Vivid | Director | 2007-03-07 | 2011-07-19 |
| SPICER, Nicholas Barry, Mr. | Director | 2018-05-02 | 2019-02-26 |
| STANDERWICK, Sharon | Director | 2015-06-29 | 2018-06-11 |
| STEWART, Daniel William | Director | 2012-12-01 | 2017-07-26 |
| SZITA, Christian | Director | 2014-10-11 | 2017-01-19 |
| TREVOR, David | Director | 2005-06-01 | 2009-12-11 |
| TUNNEY JR, Francis Richard | Director | 1993-09-14 | 2001-07-22 |
| VINCENT, Sara Jayne | Director | 2015-03-30 | 2016-01-27 |
| WILLIAMS, Judy | Director | 2005-06-01 | 2007-01-02 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Abbvie Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-12-16 | Active |
| Allergan Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-12-16 |
Filing timeline
Last 20 of 249 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-14 | CH01 | officers | Change person director company with change date | |
| 2025-08-18 | AA | accounts | Accounts with accounts type full | |
| 2025-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-10 | AA | accounts | Accounts with accounts type full | |
| 2024-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-26 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-10 | AA | accounts | Accounts with accounts type full | |
| 2023-06-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-10 | AA | accounts | Accounts with accounts type full | |
| 2022-06-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-13 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2022-04-13 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2021-12-03 | TM01 | officers | Termination director company with name termination date | |
| 2021-11-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2021-11-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2021-10-07 | AA | accounts | Accounts with accounts type full | |
| 2021-06-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-10-07 | AP03 | officers | Appoint person secretary company with name date | |
| 2020-10-06 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2020-10-05 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
0%
£13,000 £13,000
-
Net assets
+4%
£219,088,000 £227,883,000
-
Employees
—
Not reported
-
Profit before tax
+11%
£10,280,000 £11,410,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers